| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |